Top Stories
-
Source:
CUIMC NewsroomSadelain, a physician-scientist known for breakthrough work on CAR-T therapy, will lead a new cell engineering and therapy initiative at Columbia
Topic
-
Dr. Ran Reshef, director of the Cell Therapy Program at Columbia, discusses his lab's new approaches to cell therapies.
-
New proof-of-concept study in Nature Biotechnology shows that changing only a single letter in the DNA code of selected genes in T cells may lead to improved cell therapy.
Topic
-
Two research teams led by experts in oncology and engineering have won pilot grants from the Herbert Irving Comprehensive Cancer Center and Columbia Engineering.
Topic
Latest News
- December 22, 2020
CAR T-cell therapy is a promising type of treatment that re-engineers a patient’s white blood cells to recognize and kill tumor cells.
